Ology Bioservices, Inc.

05/06/2021

, now part of Resilience, is a proud sponsor of the 24th meeting of the American Society of Gene & Cell Therapy, May 11-14, 2021. Go to https://annualmeeting.asgct.org/

04/12/2021

We at are pleased to be a member of Resilience.

Resilience continues expansion with acquisition of biologics manufacturing company Ology Bioservices.

03/29/2021

is a proud sponsor of the virtual event hosted by Alliance for Regenerative Medicine. Visit our booth for information on our services.

https://meetingonthemed.com

03/10/2021

& Part 2 with 's President & CEO, Dr. Peter Khoury.

Check it out below:

03/09/2021

’s Inspiring Women Leaders Tackle Tough Topics!
Join Doris Snow, Angela Mejia and Barbel Eppler for the Day 2 Coffee Break at virtual conference. You won’t want to miss this.

03/08/2021

Happy to the amazing ladies at and all over the globe, !

03/04/2021

Join the conversation! women leaders Doris Snow, Sara Terpening & Barbel Eppler host the Day 2 Coffee Break with highly relevant topics for women leaders of today and tomorrow. March 8-9. Learn more at https://iwl.aa.ufl.edu.

02/02/2021

’s Jerrod Denham and an expert panel shared their knowledge on creating robust processes at the Phacilitate Evnt Advanced Therapeutics Connect virtual event, last week. Watch the discussion on Phacilitate's Youtube channel at https://youtu.be/L80j-wYaYkY

Below is an excerpt from the panel discussion, where Jerrod introduces himself, Ology Bio and our new Cell and ex vivo Gene Therapy facility.

Watch Jerrod's exclusive interview 'Creating a Next-Gen CDMO, an interview with Jerrod Denham, VP Manufacturing, Ology Bioservices' on Phacilitate's Youtube channel at
https://youtu.be/EtR0eX3XbYQ

01/25/2021

On January 27th, join as we watch our own Jerrod Denham and a fantastic panel of experts share what they have learned about creating robust processes. Ology Bioservices is a Silver Sponsor of Phacilitate Evnt (Virtual) Advanced Therapeutics Connect 2021.
https://www.advancedtherapiesconnect.com/

01/21/2021

's new VP of Manufacturing, Jerrod Denham, shares his vision of our new Cell and ex vivo Gene Therapy facility, in Alameda, CA.

Find out how we are 'Creating a Next Generation CDMO' by watching the full interview at Phacilitate Exchange, as this week's Editor's Pick. Go to: https://www.phacilitate.co.uk/article/creating-next-generation-cdmo

In this interview, we speak with Jerrod Denham, VP of Manufacturing at Ology Bioservices about how the company is expanding their CDMO services to include cell and ex vivo gene therapies at a new location in the San Francisco area.